Phase II Study of Oxaliplatin + 5-FluoroUracil/Leucovorin (Eloxatin+5-FU/LV) in Patients With Unresectable Hepatocellular Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 12 Mar 2010
At a glance
- Drugs Fluorouracil; Folinic acid; Oxaliplatin
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Sanofi
- 12 Mar 2010 Actual patient number (38) added as reported by ClinicalTrials.gov.
- 12 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Dec 2009 Planned end date changed from 1 Dec 2009 to 1 Jan 2010 as reported by ClinicalTrials.gov.